Husband currently doing docetaxel had second infusion on 09/13/22
Also suffers from psoriasis
Nubeqa has been shown to be an effective therapy
August 5, 2022, the Food and Drug Administration approved darolutamide (Nubeqa, Bayer HealthCare Pharmaceuticals Inc.) tablets in combination with docetaxel for adult patients with metastatic hormone-sensitive prostate cancer (mHSPC).
Found this online:
How effective is Nubeqa?
Nubequa treated patients survived an average of 40.4 months without evidence of metastases compared to only 18.4 for individuals treated with ADT alone. Nubeqa resulted in a 31% reduction in the risk of death from prostate cancer.Aug 11, 202
NUBEQA® (darolutamide) is a prescription medicine used to treat adults with prostate cancer: that has not spread to other parts of the body and no longer responds to medical or surgical treatment that lowers testosterone (nmCRPC)